Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Advanced Biomed Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Advanced Biomed Inc (ADVB) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2026

API endpoints for this dataset

                        https://api.csimarket.com/api/v1/companies/ADVB/competitors                    

                        https://api.csimarket.com/api/v1/companies/ADVB/relationships                    

                        https://api.csimarket.com/api/v1/companies/ADVB/similar                    

Programmatic access for models, analytics, and integration workflows.

Pull these exact ratios programmatically

Get an API key License this feed for redistribution / AI →

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AI Integration via MCP

Connect Claude, ChatGPT, or any MCP-compatible AI assistant directly to this data.

ADVB Stock Performance relative to its Competitors

ADVB Competitors (weighted) Percent change over the selected range

Advanced Biomed Inc's Comment on Competition and Industry Peers

The State Administration for Market Regulation (SAMR) issued draft provisions addressing unfair competition on the internet, including prohibitions on using data or algorithms to hijack traffic, fabricating misleading information to harm competitors' reputations, and employing fake reviews or coupons to generate positive ratings. The Anti-Monopoly Commission of the State Council published guidelines defining circumstances under which internet platform activities are considered monopolistic and outlined procedures for concentration filings. Violations of the PRC Anti-Monopoly Law may result in orders to terminate illegal concentrations.

Competitor data is not yet available for Advanced Biomed Inc.